Sophie Bosset

An accomplished, ambitious, entrepreneurial-minded, patient-centric and global cross-functional leader with 20 years of experience in pharmaceutical industry (small and large size pharma) with leadership, operational and managerial expertise in late phase compound development programs including new product filings and launches. Strong track record of driving improvements to overall organisational performance, through the implementation of value-adding processes, and experience in corporate integrations. Proven success in building and leading global, multi-functional, high-performing teams towards delivering pipelines and complex portfolios of transformational medicines. Skilled in partnering and communicating with senior R&D and commercial leaders to influence decisions and shaping strategies. Strong ability to manage people from global and regional teams in a matrix environment. Competencies in managing resources, global program and department budgets and department in alignment with global strategies.

• 2017 - Present, Johnson & Johnson, Switzerland
• 2014 - 2017, Actelion Pharmaceuticals Ltd., Switzerland
• 2010-2014, Novartis Pharma AG, Switzerland
• 2005-2010, Novartis Institutes for Biomedical Research, Switzerland
• 2004-2005, University of Chicago, USA

• 1999-2002, PhD in Clinical Immunology, Pr J.F. Nicolas - Claude Bernard University, Lyon, France
• 1998-1999, Master in Clinical Immunology, Pr W.H. Fridman - Necker University, Paris, France
• 1997-1998, Bachelor in Molecular Biology and Biochemistry, Lyon, France
• 1993-1998, School of Veterinary Medicine, Lyon, France

• ASCEND (2021)
• R&D Leadership Award for Actelion's integration into Janssen organization (2019)
• R&D Leadership Oscar (2017)

ASCEND